Literature DB >> 23255176

Precision of pulmonary vein diameter measurements assessed by CE-MRA and steady-state-free precession imaging.

Michael Groth1, Peter Bannas, Marc Regier, Jan H Buhk, Kai Müllerleile, Gerhard Adam, Frank O Henes.   

Abstract

OBJECTIVE: Pulmonary vein (PV) diameter assessment is important for planning and follow-up of PV ablation in atrial fibrillation. Therefore, the aim of our study was to evaluate inter- and intraobserver reliability of PV diameter measurements by contrast-enhanced magnetic resonance angiography (CE-MRA) and ECG-gated 2D multislice unenhanced steady-state-free precession sequences (multislice SSFP).
METHODS: Sixty PV diameters in 17 consecutive patients were measured in transverse and coronal orientation with CE-MRA and multislice SSFP by two observers. Statistics to evaluate inter- and intraobserver reliability included Bland-Altman analysis and F-test.
RESULTS: Intraobserver limits of agreement (LAG) ranged between ±0.50 cm (transverse) and ±0.86 cm (coronal) for CE-MRA versus ±0.40 cm (transverse) and ±0.67 cm (coronal) for multislice SSFP. Interobserver agreement showed LAG ranging between ±0.59 cm (transverse) and ±0.83 cm (coronal) for CE-MRA versus ±0.34 cm (transverse) and ±0.75 cm (coronal) for multislice SSFP. Intra- and interobserver variances did not reveal significant differences between CE-MRA and multislice SSFP in any orientation (all p-values >0.05).
CONCLUSION: Multislice SSFP and CE-MRA enable comparable precision of PV diameter measurements. However, both methods reveal a wide range of intra- and interobserver agreement, which has to be thoroughly considered in clinical use. KEY POINTS: • Unenhanced magnetic resonance imaging can now provide measurement of pulmonary vein diameters • Steady-state-free precession offers a new method of performing unenhanced MR imaging • Both unenhanced and enhanced MRI measurements show wide intra- and interobserver variation • PV diameter measurements assessed by MRI have to be interpreted with care • Nevertheless, unenhanced MRI might replace some CT examinations for pulmonary vein demonstration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255176     DOI: 10.1007/s00330-012-2752-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  23 in total

1.  MR evaluation of pulmonary vein diameter reduction after radiofrequency catheter ablation of atrial fibrillation.

Authors:  Frédéric Anselme; Gérald Gahide; Arnaud Savouré; Edouard Gerbaud; Mikael Mabru; Alain Cribier; Jean-Nicolas Dacher
Journal:  Eur Radiol       Date:  2006-04-26       Impact factor: 5.315

2.  A method for the determination of proximal pulmonary vein size using contrast-enhanced magnetic resonance angiography.

Authors:  Thomas H Hauser; Susan B Yeon; Seth McClennen; George Katsimaglis; Kraig V Kissinger; Mark E Josephson; Neil M Rofsky; Warren J Manning
Journal:  J Cardiovasc Magn Reson       Date:  2004       Impact factor: 5.364

3.  Unenhanced MR angiography of the thoracic aorta: initial clinical evaluation.

Authors:  Christopher J François; David Tuite; Vibhas Deshpande; Renate Jerecic; Peter Weale; James C Carr
Journal:  AJR Am J Roentgenol       Date:  2008-04       Impact factor: 3.959

4.  Improved agreement between experienced and inexperienced observers using a standardized evaluation protocol for cardiac volumetry and infarct size measurement.

Authors:  M Groth; K Muellerleile; T Klink; D Säring; S Halaj; G Folwarski; M Kaul; P Bannas; G Adam; G K Lund
Journal:  Rofo       Date:  2012-09-21

5.  Anxiety in patients undergoing MR imaging.

Authors:  M E Quirk; A J Letendre; R A Ciottone; J F Lingley
Journal:  Radiology       Date:  1989-02       Impact factor: 11.105

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  [Multicenter analysis of tolerance and clinical safety of the extracellular MR contrast agent gadobenate dimeglumine (MultiHance)].

Authors:  C U Herborn; I Jäger-Booth; K P Lodemann; A Spinazzi; M Goyen
Journal:  Rofo       Date:  2009-03-16

Review 8.  Percutaneous ablation for atrial fibrillation: the role of cross-sectional imaging.

Authors:  Benoit Ghaye; David Szapiro; Jean-Nicolas Dacher; Luz-Maria Rodriguez; Carl Timmermans; David Devillers; Robert F Dondelinger
Journal:  Radiographics       Date:  2003-10       Impact factor: 5.333

9.  Nephrogenic systemic fibrosis: a report of 29 cases.

Authors:  Wael M Shabana; Richard H Cohan; James H Ellis; Hero K Hussain; Isaac R Francis; Lyndon D Su; Suresh K Mukherji; Richard D Swartz
Journal:  AJR Am J Roentgenol       Date:  2008-03       Impact factor: 3.959

10.  Pulmonary vein imaging with unenhanced three-dimensional balanced steady-state free precession MR angiography: initial clinical evaluation.

Authors:  Christopher J François; David Tuite; Vibhas Deshpande; Renate Jerecic; Peter Weale; James C Carr
Journal:  Radiology       Date:  2009-01-22       Impact factor: 11.105

View more
  1 in total

1.  Assessment of thoracic vasculature in patients with central bronchogenic carcinoma by unenhanced magnetic resonance angiography: comparison between 2D free-breathing TrueFISP, 2D breath-hold TrueFISP and 3D respiratory-triggered SPACE.

Authors:  Lili Wang; Peng Lv; Shuohui Yang; Mengsu Zeng; Jiang Lin
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.